Identification of aurintricarboxylic acid as a selective inhibitor of the TWEAK-Fn14 signaling pathway in glioblastoma cells

The survival of patients diagnosed with glioblastoma (GBM), the most deadly form of brain cancer, is compromised by the proclivity for local invasion into the surrounding normal brain, which prevents complete surgical resection and contributes to therapeutic resistance. Tumor necrosis factor-like we...

Descripción completa

Detalles Bibliográficos
Autores principales: Roos, Alison, Dhruv, Harshil D., Mathews, Ian T., Inge, Landon J., Tuncali, Serdar, Hartman, Lauren K., Chow, Donald, Millard, Nghia, Yin, Holly H., Kloss, Jean, Loftus, Joseph C., Winkles, Jeffrey A., Berens, Michael E., Tran, Nhan L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5355340/
https://www.ncbi.nlm.nih.gov/pubmed/28103571
http://dx.doi.org/10.18632/oncotarget.14685

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5355340/
https://www.ncbi.nlm.nih.gov/pubmed/28103571
http://dx.doi.org/10.18632/oncotarget.14685

Ejemplares similares